Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

NCT00084396 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
115
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Washington University School of Medicine

Collaborators